Related references
Note: Only part of the references are listed.A Pyroptosis-Related Gene Prognostic Index Correlated with Survival and Immune Microenvironment in Glioma
Jianglin Zheng et al.
JOURNAL OF INFLAMMATION RESEARCH (2022)
Phase I/II trial of vorinostat and radiation and maintenance vorinostat in children with diffuse intrinsic pontine glioma: A Children's Oncology Group report
Jack M. Su et al.
NEURO-ONCOLOGY (2022)
Clinical and Biological Significance of a Necroptosis-Related Gene Signature in Glioma
Zunjie Zhou et al.
FRONTIERS IN ONCOLOGY (2022)
An Immune-Related lncRNA Signature to Predict Survival In Glioma Patients
Pengfei Xia et al.
CELLULAR AND MOLECULAR NEUROBIOLOGY (2021)
DIVERSITY AND BIOLOGY OF CANCER-ASSOCIATED FIBROBLASTS
Giulia Biffi et al.
PHYSIOLOGICAL REVIEWS (2021)
MEX3A contributes to development and progression of glioma through regulating cell proliferation and cell migration and targeting CCL2
Chao Yang et al.
CELL DEATH & DISEASE (2021)
Chinese Glioma Genome Atlas (CGGA) : A Comprehensive Resource with Functional Genomic Data from Chinese Glioma Patients
Zheng Zhao et al.
GENOMICS PROTEOMICS & BIOINFORMATICS (2021)
Venn diagrams in bioinformatics
Anqiang Jia et al.
BRIEFINGS IN BIOINFORMATICS (2021)
Endoplasmic Reticulum Stress Contributes to Gefitinib-Induced Apoptosis in Glioma
Cheng-Yi Chang et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
A risk signature with four autophagy-related genes for predicting survival of glioblastoma multiforme
Yulin Wang et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2020)
CDK4/6 inhibition suppresses tumour growth and enhances the effect of temozolomide in glioma cells
Yingxiao Cao et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2020)
Tumor Microenvironment Is Critical for the Maintenance of Cellular States Found in Primary Glioblastomas
Allison R. Pine et al.
CANCER DISCOVERY (2020)
Genomic copy number variation correlates with survival outcomes in WHO grade IV glioma
Zachary S. Buchwald et al.
SCIENTIFIC REPORTS (2020)
Antitumor effect of lenalidomide in malignant glioma cell lines
Yuya Hanashima et al.
ONCOLOGY REPORTS (2020)
Management of glioblastoma: State of the art and future directions
Aaron C. Tan et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2020)
Bioinformatic Profiling of Prognosis-Related Genes in Malignant Glioma Microenvironment
Yong Li et al.
MEDICAL SCIENCE MONITOR (2020)
Aging-related tumor associated fibroblasts changes could worsen the prognosis of GBM patients
Hongwang Song et al.
CANCER CELL INTERNATIONAL (2020)
Axitinib plus avelumab in the treatment of recurrent glioblastoma: a stratified, open-label, single-center phase 2 clinical trial (GliAvAx)
Gil Awada et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2020)
Identification of Prognostic Model and Biomarkers for Cancer Stem Cell Characteristics in Glioblastoma by Network Analysis of Multi-Omics Data and Stemness Indices
Jianyang Du et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2020)
Cancer-associated fibroblast (CAF)-derived IL32 promotes breast cancer cell invasion and metastasis via integrin β3-p38 MAPK signalling
Siyang Wen et al.
CANCER LETTERS (2019)
Cancer-associated fibroblasts in gastrointestinal cancer
Hiroki Kobayashi et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2019)
Physical and Molecular Landscapes of Mouse Glioma Extracellular Vesicles Define Heterogeneity
Aron Gyuris et al.
CELL REPORTS (2019)
Electrical and synaptic integration of glioma into neural circuits
Humsa S. Venkatesh et al.
NATURE (2019)
Chi-square Tests in Medical Research
Patrick Schober et al.
ANESTHESIA AND ANALGESIA (2019)
Molecular targeted therapy of glioblastoma
Emilie Le Rhun et al.
CANCER TREATMENT REVIEWS (2019)
Turning foes to friends: targeting cancer-associated fibroblasts
Xueman Chen et al.
NATURE REVIEWS DRUG DISCOVERY (2019)
Delivery technologies for cancer immunotherapy
Rachel S. Riley et al.
NATURE REVIEWS DRUG DISCOVERY (2019)
Imaging Genetic Heterogeneity in Glioblastoma and Other Glial Tumors: Review of Current Methods and Future Directions
Daniel Chow et al.
AMERICAN JOURNAL OF ROENTGENOLOGY (2018)
Fibroblast heterogeneity: implications for human disease
Magnus D. Lynch et al.
JOURNAL OF CLINICAL INVESTIGATION (2018)
Immune-Related Adverse Events Associated with Immune Checkpoint Blockade
Michael A. Postow et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Immune Microenvironment in Glioblastoma Subtypes
Zhihong Chen et al.
FRONTIERS IN IMMUNOLOGY (2018)
Primary brain tumours in adults
Sarah Lapointe et al.
LANCET (2018)
Extracellular Matrix and Colorectal Cancer: How Surrounding Microenvironment Affects Cancer Cell Behavior?
Sara Crotti et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2017)
Temozolomide with or without Radiotherapy in Patients with Newly Diagnosed Glioblastoma Multiforme: A Meta-Analysis
Enshan Feng et al.
EUROPEAN NEUROLOGY (2017)
Pediatric Gliomas: Current Concepts on Diagnosis, Biology, and Clinical Management
Dominik Sturm et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
CBTRUS Statistical Report: Primary brain and other central nervous system tumors diagnosed in the United States in 2010-2014
Quinn T. Ostrom et al.
NEURO-ONCOLOGY (2017)
Knockdown of Angiopoietin-Like Protein 2 Inhibits Proliferation and Invasion in Glioma Cells via Suppressing the ERK/MAPK Signaling Pathway
Li-Kun Yang et al.
ONCOLOGY RESEARCH (2017)
Temporally Distinct PD-L1 Expression by Tumor and Host Cells Contributes to Immune Escape
Takuro Noguchi et al.
CANCER IMMUNOLOGY RESEARCH (2017)
A comprehensive profile of recurrent glioblastoma
B. Campos et al.
ONCOGENE (2016)
Mechanism-driven biomarkers to guide immune checkpoint blockade in cancer therapy
Suzanne L. Topalian et al.
NATURE REVIEWS CANCER (2016)
Estimating the population abundance of tissue-infiltrating immune and stromal cell populations using gene expression
Etienne Becht et al.
GENOME BIOLOGY (2016)
A preclinical study demonstrating the efficacy of nilotinib in inhibiting the growth of pediatric high-grade glioma
Karolyn Au et al.
JOURNAL OF NEURO-ONCOLOGY (2015)
Targeting PBK/TOPK decreases growth and survival of glioma initiating cells in vitro and attenuates tumor growth in vivo
Mrinal Joel et al.
MOLECULAR CANCER (2015)
Stromal fibroblast in age-related cancer: role in tumorigenesis and potential as novel therapeutic target
Abdelouahid Elkhattouti et al.
FRONTIERS IN ONCOLOGY (2015)
pRRophetic: An R Package for Prediction of Clinical Chemotherapeutic Response from Tumor Gene Expression Levels
Paul Geeleher et al.
PLOS ONE (2014)
Decreased miR-106a inhibits glioma cell glucose uptake and proliferation by targeting SLC2A3 in GBM
Dong-Wei Dai et al.
BMC CANCER (2013)
DNA Methylation and Its Basic Function
Lisa D. Moore et al.
NEUROPSYCHOPHARMACOLOGY (2013)
Genomics of Drug Sensitivity in Cancer (GDSC): a resource for therapeutic biomarker discovery in cancer cells
Wanjuan Yang et al.
NUCLEIC ACIDS RESEARCH (2013)
Accessories to the Crime: Functions of Cells Recruited to the Tumor Microenvironment
Douglas Hanahan et al.
CANCER CELL (2012)
clusterProfiler: an R Package for Comparing Biological Themes Among Gene Clusters
Guangchuang Yu et al.
OMICS-A JOURNAL OF INTEGRATIVE BIOLOGY (2012)
SubMAP: Aligning Metabolic Pathways with Subnetwork Mappings
Ferhat Ay et al.
JOURNAL OF COMPUTATIONAL BIOLOGY (2011)
Immune surveillance of tumors
Jeremy B. Swann et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Role of cancer-associated stromal fibroblasts in metastatic colon cancer to the liver and their expression profiles
H Nakagawa et al.
ONCOGENE (2004)